MAPT and Alzheimer disease: Two other groups also recently reported that CSF sTREM2 levels are elevated in AD cases compared to cognitively normal controls and that sTREM2 levels are correlated with CSF tau and ptau (Heslegrave et al, 2016; Piccio et al, 2016).